Development and validation of CNN-MLP models for predicting anti-VEGF therapy outcomes in diabetic macular edema
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Development and validation of CNN-MLP models for predicting anti-VEGF therapy outcomes in diabetic macular edema ; volume:14 ; number:1 ; day:4 ; month:12 ; year:2024 ; pages:1-9 ; date:12.2024
Scientific reports ; 14, Heft 1 (4.12.2024), 1-9, 12.2024
- Klassifikation
-
Ingenieurwissenschaften und Maschinenbau
- Urheber
-
Leng, Xiangjie
Shi, Ruijie
Xu, Zhaorui
Zhang, Hai
Xu, Wenxuan
Zhu, Keyin
Lu, Xuejing
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-82007-4
- URN
-
urn:nbn:de:101:1-2502182123581.400292263420
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Leng, Xiangjie
- Shi, Ruijie
- Xu, Zhaorui
- Zhang, Hai
- Xu, Wenxuan
- Zhu, Keyin
- Lu, Xuejing
- SpringerLink (Online service)
Ähnliche Objekte (12)
Anti-VEGF for the management of diabetic macular edema
Vitreomacular interface after anti-VEGF injections in diabetic macular edema
Visual and anatomic outcomes of sustained single agent anti-VEGF treatment versus double anti-VEGF switching in the treatment of persistent diabetic macular edema
Cost-consequence analysis of extended loading dose of anti-VEGF treatment in diabetic macular edema patients
Predictive effect of TCED-HFV grading and imaging biomarkers on anti-VEGF therapy in diabetic macular edema
Effect of intraocular anti-VEGF on cystoid macular edema associated with Henoch-Schonlein purpura-a case report
Hyperreflective Foci in Diabetic Macular Edema with Subretinal Fluid: Association with Visual Outcomes after Anti-VEGF Treatment
Anti-VEGF therapy for the long-term management of diabetic macular edema: a treat-to-target strategy based on macular morphology
Visual outcomes of observation, macular laser and anti-VEGF in diabetic macular edema in type 1 diabetes: a real-world study
Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
Genome-wide association study of the response of patients with diabetic macular edema to intravitreal Anti-VEGF injection
Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema
Anti-VEGF for the management of diabetic macular edema
Vitreomacular interface after anti-VEGF injections in diabetic macular edema
Visual and anatomic outcomes of sustained single agent anti-VEGF treatment versus double anti-VEGF switching in the treatment of persistent diabetic macular edema
Cost-consequence analysis of extended loading dose of anti-VEGF treatment in diabetic macular edema patients
Predictive effect of TCED-HFV grading and imaging biomarkers on anti-VEGF therapy in diabetic macular edema
Effect of intraocular anti-VEGF on cystoid macular edema associated with Henoch-Schonlein purpura-a case report
Hyperreflective Foci in Diabetic Macular Edema with Subretinal Fluid: Association with Visual Outcomes after Anti-VEGF Treatment
Anti-VEGF therapy for the long-term management of diabetic macular edema: a treat-to-target strategy based on macular morphology
Visual outcomes of observation, macular laser and anti-VEGF in diabetic macular edema in type 1 diabetes: a real-world study
Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
Genome-wide association study of the response of patients with diabetic macular edema to intravitreal Anti-VEGF injection
Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema
Anti-VEGF for the management of diabetic macular edema
Vitreomacular interface after anti-VEGF injections in diabetic macular edema
Visual and anatomic outcomes of sustained single agent anti-VEGF treatment versus double anti-VEGF switching in the treatment of persistent diabetic macular edema
Cost-consequence analysis of extended loading dose of anti-VEGF treatment in diabetic macular edema patients
Predictive effect of TCED-HFV grading and imaging biomarkers on anti-VEGF therapy in diabetic macular edema
Effect of intraocular anti-VEGF on cystoid macular edema associated with Henoch-Schonlein purpura-a case report
Hyperreflective Foci in Diabetic Macular Edema with Subretinal Fluid: Association with Visual Outcomes after Anti-VEGF Treatment
Anti-VEGF therapy for the long-term management of diabetic macular edema: a treat-to-target strategy based on macular morphology
Visual outcomes of observation, macular laser and anti-VEGF in diabetic macular edema in type 1 diabetes: a real-world study
Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
Genome-wide association study of the response of patients with diabetic macular edema to intravitreal Anti-VEGF injection